COMPETENCE IN NUCLEAR MEDICINE
Deutsch
English
Français
Italiano
Anker
Inhalt Top

IASOcholine®

[18F] fluorocholine

Therapeutic indications

IASOcholine is a diagnostic reagent for the positron emission tomography (PET) and is administered prior to such an examination.

The radioactive agent of IASOcholine enables the graphic representation of an increased intake of the naturally occurring substance choline in specific organs or tissues and is recorded by the PET and displayed as an image.

In particular, the following indications were documented for PET with fluorocholine (18F):

  • Prostate cancer
  • Detection of bone metastases with regard to prostate cancer

Hepatocellular carcinoma

  • Localisation of lesions in well differentiated hepatocellular carcinoma
  • Characterisation of liver knots and/or “staging“ of hepatocellular carcinoma, if PET with FDG is not conclusive and/or a surgical procedure is scheduled

CLINICAL PARTICULARS

Approvals

Approval number Date of registration Country PDF
576 946-1 02.04.2010 France SPC
81779.00.00 19.07.2011 Germany SPC
4-00044 25.08.2011 Austria SPC
Inhalt Bottom